On September 25-26 the COST Action “Networking towards clinical application of antisense-mediated exon skipping” organized a workshop on antisense oligonucleotide delivery in Leiden. The meeting was organized by the Action Chair (Annemieke Aartsma-Rus) and was attended by scientists working on exon skipping, antisense oligonucleotides as well a liver specialist.
Participants came from the France (Aurélie Goyenvalle, France Pietri-Rouxel and Françoise Rouault), Germany (Sabine Krause), Israel (Anwar Rayan), the Netherlands (Annemieke Aartsma-Rus and Ingrid Verhaart), Norway (Bård Smedsrod), Spain (Virginia Arechevala-Gomeza, Lorena Gallego-Villar and Lourdes Ruiz Desviat) and the United Kingdom (Mike Gait, Linda Popplewell, Nic Wells and Matthew Wood). Participants presented current work and discussed delivery challenges under a confidentiality agreement.
Future workshops will focus on oligonucleotide delivery to brain (January 2014, organized by Annemieke Aartsma-Rus, Aurélie Goyenvalle and Matthew Wood) and oligonucleotide chemistry and toxicology (April 2014, organized by Annemieke Aartsma-Rus, Samir El Andaloussi and Mike Gait).
Note that participation to this COST Action is open to everyone residing in a COST country (see link for a list of COST countries) willing and able to contribute towards the objectives. Please contact Annemieke Aartsma-Rus for more information or explore this website to learn more.
Note also that COST Actions provide opportunities for researchers to visit a lab in another COST country for 5-90 days to contribute to the scientific objectives of the Action and allow applicants to learn new techniques or gain access to specific instruments and/or methods not available in their own institution. Up to €2500 is available per researcher for at least 4 individuals per year. Please check the short term scientific missions page for more information.
